Skip to main content

Table 1 Obstetric and neonatal characteristics of pregnancies extending beyond 20 weeks gestation

From: Case report: Glycaemic management and pregnancy outcomes in a woman with an insulin receptor mutation, p.Met1180Lys

Offspring no.

1

2

3

4

5

6 (Twin 1)

7 (Twin 2)

8

Maternal age

21

22

33

34

35

36

36

38

Gender

M

F

F

M

F

F

M

M

Genotype of offspring

N/T

INSR+

INSR+

INSR+

INSR-

INSR+

N/T

N/T

Metformin

0

0

2 g/day

2 g/day

2 g/day

2 g/day until trimester 2

2 g/day until trimester 2

2 g/day

First trimester TDD insulin, units (unit/kg)

110 (1.47)

100 (1.27)

88 (1.25)

66 (0.91)

46 (0.66)

51 (0.68)

51 (0.68)

68 (0.9)

Third trimester TDD insulin, units (unit/kg)

120 (1.54)

134 (1.68)

83 (1.1)

71 (0.96)

46 (0.58)

111 (1.26)

111 (1.26)

120 (1.4)

Booking fructosamine (nmol/l)

280

283

304

365

333

331

331

368

Third trimester fructosamine (nmol/l)

230

235

224

224

224

235

Booking HbA1c (mmol/mol)

56

64

67

74

80

80

80

83

Third trimester HbA1c (mmol/mol)

39

45

55

55

55

52

Status at birth

Neonatal death

Live birth

Live birth

Live birth

Live birth

Live birth

IUD

IUD

Birthweight (kg)

0.5

0.74

2.87

3.11

3.52

2.2

2.5

3.52

Gestation (weeks)

21+2

26+4

38

38

38+3

36+2

36+2 (foetal demise at 32w)

35+3

Birth centile

n/a

5

40

66

94

9

100

100

Type of delivery

SVD

SVD

EmCS (failed IOL)

ELCS

ELCS

ELCS

ELCS

ELCS

Offspring complications

Placental insufficiency

HH, VSD, pulmonary hypoplasia, developmental delay, autism

 

T1DM age 2, IA-2, ZnT8 positive [8]

   

VSD

  1. M male, F female, N/T not genetically tested, INSR+ insulin receptor mutation positive, INSR- insulin receptor mutation negative, TDD total daily dose, IUD intrauterine death, n/a not applicable, SVD spontaneous vaginal delivery, EmCS emergency caesarean section, IOL induction of labour, ELCS elective caesarean section, HH hyperinsulinaemic hypoglycaemia, VSD ventricular septal defect, T1DM type 1 diabetes, IA-2 islet tyrosine phosphatase 2 antibodies, ZnT8 zinc transporter 8 antibodies